北京友谊医院2012～2013年病房药房口服降糖药使用分析  

Analysis of the Use of Oral Hypoglycemic Drugs in the Ward of Beijing Friendship Hospital during 2012～2013

作　　者：马静[1] 沈素[1] Ma Jing;Shen Su(Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China)

机构地区：[1]首都医科大学附属北京友谊医院药学部,北京100050

出　　处：《中国医药导刊》2016年第7期716-717,共2页Chinese Journal of Medicinal Guide

摘　　要：目的：对我院2012～2013年住院患者口服降糖药物使用情况进行分析。方法：对我院2012～2013年患者住院期间使用口服降糖药物的销售金额、用药频度（DDDs）、限定日费用（DDC）等进行回顾性统计分析，利用销售金额与DDDs排序比分析用药同步性。结果：我院口服降糖药物使用量呈逐年上升趋势，2012～2013年患者使用口服降糖药物的DDDs前三位分别是阿卡波糖、二甲双胍、格列喹酮，符合临床用药趋势和治疗原则。结论：我院2012～2013年口服降糖药物使用情况基本合理。Objective: To compare and analyze the usage of oral hypoglycemic drugs in our hospital during 2012~2013. Methods:Sales amount of oral hypoglycemic drugs, DDDs (DDDs) and defined daily cost (DDC) were retrospectively analyzed of inpatientsin our hospital during 2012~2013. Analyze the use of oral hypoglycemic drugs according to the DDDs order and sum order. Results:Oral hypoglycemic agents in our hospital drug usage showed a rising trend year by year, 2012~2013 patients using the DDDs of oralhypoglycemic drugs three are acarbose, metformin, Gliquidone, conforms to the trends in clinical medicine and treatment principles.Conclusions: The use of oral hypoglycemic drugs in our hospital during 2012~2013 was basically reasonable.

关 键 词：口服降糖药物 用药频度 销售金额 限定日费用 使用分析 

分 类 号：R977.15[医药卫生—药品]